GC WellBeing affiliate Inibio receives Chinese approval for botulinum toxin 'Inybo'
Predicted impact: Low
Chinese approval for affiliate's botulinum toxin; small relative to parent company's size.
GC WellBeing녹십자웰빙
234690 · KOSDAQ · ₩234690 · 녹십자웰빙
₩10,870▼ ₩360 (3.21%)End-of-day · Oct 26, 2026 · End-of-day prices.
Price · 1Y +16.51%
- Market cap
- ₩195B
- Enterprise value
- ₩270B
- P/E
- 14.3×
- P/B
- 1.7×
- Dividend yield
- 1.3%
- ROE
- 11.9%
- Net margin
- 7.1%
Trailing 12 months from filed financial statements, as of H1 2026. Dividend yield: the 2025 dividend per share from the annual report ÷ today's price.
52-week range−31.6% from the high
₩6,680Today: ₩10,570 – ₩11,500₩15,890
Returns
- 1W−4.2%
- 1M+21.2%
- 3M+34.0%
- 6M−23.5%
- YTD+18.9%
- 1Y+17.8%
- Volume today
- 274,136
- 0.9× the 20-day average
- Traded today
- ₩3B
- Listed shares
- 17,963,290
- EPS (12 months)
- ₩759
- Earnings yield 7.0%
AI research · InitiationGC WellBeing: Rising Revenue and Profit, Negative Free Cash Flow, and a Wide Model RangeThe filed numbers show a company growing revenue and profit, with ROE improving and a P/E below its own recent history.Read the full report →
Upcoming dates
Full calendar →🎁 Gift this stock
Send a friend ₩100,000 of paper money in this stock. They get it when they join.
Signals
Normal- BuzzNormalBuzz 47 of 100 (50 is a normal day for this stock).
- SentimentPositiveNews: Regulatory approval in China is a positive development. Community: 0 bullish, 0 bearish posts this week.
- MomentumStrong19.8% over the last month; the price is above its 20-day average.
- News impactLow1 news items and filings in two weeks; 0 rated high impact, 0 medium.
Signals describe activity, not recommendations. Not financial advice.
GC WellBeing stock overview
GC WellBeing (녹십자웰빙, KRX: 234690) is listed on KOSDAQ, in the Biotech & Pharma sector. PNT brand. Its shares closed at ₩10,870 on Oct 26, 2026, down 3.21% on the day, giving it a market value of ₩195B.
Key facts
- Market cap
- ₩195B
- Sector
- Biotech & Pharma
- Latest price change
- −3.21%
- As of
- Oct 26, 2026
- Main business
- PNT brand.
Quick answers about GC WellBeing
- What does GC WellBeing do?
- PNT brand. It also sells aesthetic medical devices and cosmetics, including HA fillers and skin boosters, primarily to hospitals, clinics, and pharmaceutical wholesalers. Its operations are based in Korea, with products also exported, including to China.
- What is the market cap of GC WellBeing?
- The market capitalisation of GC WellBeing was ₩195B at the close on Oct 26, 2026.
- Who are the largest shareholders of GC WellBeing?
- According to the latest official filings, the largest reported holders are GC Pharma (40.41%, as of Apr 7, 2026); GC Holdings (40.41%, as of Apr 7, 2026); 4 Human Life Wellbeing No. 1 Private Equity Investment (10.62%, as of Apr 9, 2026).
- When is the next earnings report from GC WellBeing?
- Korean companies rarely announce results dates in advance. Based on when GC WellBeing filed the same report in past years, its next 3q results is expected around Nov 14, 2026.
- Does the National Pension Service own GC WellBeing?
- Yes. The National Pension Service held 0.35% of GC WellBeing shares as of Dec 31, 2024.
Company profile
The company manufactures and sells prescription drugs, mainly nutritional injections such as its placental hydrolysate injection Lynec, along with dietary supplements sold through clinics under the Dr.PNT brand. It also sells aesthetic medical devices and cosmetics, including HA fillers and skin boosters, primarily to hospitals, clinics, and pharmaceutical wholesalers. Its operations are based in Korea, with products also exported, including to China.
Written by AI from the company's latest annual report.
- Korean name
- 녹십자웰빙
- Sector
- Biotech & Pharma
- Themes
- Pharmaceuticals
- CEO
- 김상현
- Founded
- Sep 2004
- Listed
- Oct 2019
- Listed shares
- 17,963,290
- Fiscal year ends
- Month 12
- Website
- www.greencrosswb.com
Similar companies
- Samsung Biologics207940 · ₩67T₩1,452,000−0.95%
- Celltrion068270 · ₩44T₩190,000−2.26%
- Alteogen196170 · ₩15T₩218,500−2.67%
- Yuhan000100 · ₩6T₩81,700−3.54%
- SK biopharmaceuticals326030 · ₩5.9T₩75,800−1.43%
- HLB028300 · ₩5.2T₩39,250−5.65%
- Hanmi Pharm128940 · ₩4.5T₩352,500−2.49%
- SAM Chun Dang Pharm000250 · ₩4.4T₩188,900−5.17%
Recent news
Recent filings
See all- Investor relations (IR) eventSep 14, 2026
- Half-year report (Jun 2026)Aug 14, 2026
- Amended: Preliminary earnings (consolidated)Jul 31, 2026
- Preliminary earnings (consolidated)Jul 31, 2026
- Status of Operation of Fair Trade Self-Compliance ProgramJul 13, 2026
Titles in Korean until English translations are added.
Also known as: GC WellBeing / 녹십자웰빙 / 234690 / KRX:234690
Source: KRX statistical information